Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/150452
Author(s): Salehi, B
Quispe, C
Sharifi-Rad, J
Martins, N
Nigam, M
Mishra, AP
Konovalov, DA
Orobinskaya, V
Abu-Reidah, IM
Zam, W
Sharopov, F
Venneri, T
Capasso, R
Kukula-Koch, W
Wawruszak, A
Koch, W
Title: Phytosterols: From Preclinical Evidence to Potential Clinical Applications
Publisher: Frontiers Media
Issue Date: 2021
Abstract: Phytosterols (PSs) are plant-originated steroids. Over 250 PSs have been isolated, and each plant species contains a characteristic phytosterol composition. A wide number of studies have reported remarkable pharmacological effects of PSs, acting as chemopreventive, anti-inflammatory, antioxidant, antidiabetic, and antiatherosclerotic agents. However, PS bioavailability is a key issue, as it can be influenced by several factors (type, source, processing, preparation, delivery method, food matrix, dose, time of administration into the body, and genetic factors), and the existence of a close relationship between their chemical structures (e.g., saturation degree and side-chain length) and low absorption rates has been stated. In this sense, the present review intends to provide in-depth data on PS therapeutic potential for human health, also emphasizing their preclinical effects and bioavailability-related issues.
DOI: 10.3389/fphar.2020.599959
URI: https://hdl.handle.net/10216/150452
Source: Frontiers in Pharmacology, vol.11:599959
Related Information: info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FPSI-GER%2F28076%2F2017/PT
Document Type: Artigo em Revista Científica Internacional
Rights: openAccess
License: https://creativecommons.org/licenses/by/4.0/
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.3389-fphar.2020.599959.pdf1.55 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons